Reportlinker Adds Oncology Market Forecast to 2015

NEW YORK, March 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Oncology Market Forecast to 2015

http://www.reportlinker.com/p0181145/Oncology-Market-Forecast-to-2015.html

Chart the future of the global oncology marketExplore the fiercely competitive oncology market with the most comprehensive resource available. Augment or build your models with deep, meticulously researched data - and expand your understanding of different drugs, classes and sub-classes.

Equip your team with 119 brand profiles, all of which contain painstaking detail:

• Historical and projected sales from 2006-2015
• Current and projected approvals
• Critical clinical trials to watch
• Analysis that places each drug in context against key competitors and market events
• Patent, generics and litigation information

After scouring the profiles, gauge your resource levels: Brand spending data tracks real-world dollars for promotion, medical affairs, market access and more - information you won't find anywhere else.

Give your teams all the oncology market research they need to make critical product decisions! 

Profiled Oncology Portfolios

Amgen

AstraZeneca

Bristol-Myers Squibb

Celgene

Eli Lilly (including ImClone)

Genzyme

GlaxoSmithKline

Johnson & Johnson

Merck (including Schering-Plough)

Novartis

Pfizer (including Wyeth)

Roche (including Genentech)

Sanofi-Aventis

All Companies Included in Report

Abbott

Abraxis

Allos Therapeutics

Amgen

AnGes

Antisoma

Ariad

ArQule

Array BioPharma

Astellas

AstraZeneca

Bayer

Bioenvision

Biovail

Bristol-Myers Squibb

Celgene

Cephalon

Chugai

Cougar

Daiichi Sankyo

Dendreon

Eisai

Eli Lilly

Enzon

Epicept

Exelixis

GenMab

Genzyme

GlaxoSmithKline

GTx

Infinity

Johnson & Johnson

Medivation

Merck

Merck KGaA

Millennium

Myriad

Nektar

Novartis

Oncothyreon

Onyx

OSI

Pfizer

PharmaMar

Poniard

Progenics

Regeneron

Roche

Sanofi-Aventis

Seattle Genetics

Sigma Tau

Taisho

Transgene

Vical

Chapter 1: Analysis of Cancer Drugs by Classes (119 Drug Profiles)

Brand Information:

Brand and generic name

Drug class

Delivery mechanism

Line of treatment

Materiality to company(ies) portfolio

Summary of key approvals

Sales Data:

Historical/current sales to 2006

Forecasted sales to 2015

Brand Analysis:

Competitive and strategic positioning (current and projected)

Market opportunities and brand growth (current and projected)

Key clinical trials to watch

Current state of product development

Patent, generic and litigation information

Chapter 2: Top Companies' Oncology Portfolios

Current and projected (2015) ranking in oncology market

Oncology revenues from 2006-2015

Share of oncology market

Analysis of competitive and strategic positioning

Breakdown of strengths, growth areas and competition

Comparison of revenue for oncology versus other therapeutic areas

Pipeline development chart

Analysis of key products

Chapter 3: Brand Spending Benchmarks

Analysis of Average Brand Spending by Budget Category:

Advertising and promotion

Decision support

Medical affairs

Market access

Analysis of Average Brand Spending by Time Period:

Pre-clinical to Phase 2

Phase 3a

Phase 3b

First year on the market

To order this report:

Medical Devices Industry: Oncology Market Forecast to 2015

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker